Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.
Moore OA, Goh N, Corte T, Rouse H, Hennessy O, Thakkar V, Byron J, Sahhar J, Roddy J, Gabbay E, Youssef P, Nash P, Zochling J, Proudman SM, Stevens W, Nikpour M. Moore OA, et al. Among authors: zochling j. Rheumatology (Oxford). 2013 Jan;52(1):155-60. doi: 10.1093/rheumatology/kes289. Epub 2012 Oct 13. Rheumatology (Oxford). 2013. PMID: 23065360
The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis.
Morrisroe KB, Stevens W, Nandurkar H, Prior D, Thakkar V, Roddy J, Zochling J, Sahhar J, Tymms K, Sturgess A, Major G, Kermeen F, Hill C, Walker J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M. Morrisroe KB, et al. Among authors: zochling j. Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-133-7. Epub 2014 Feb 24. Clin Exp Rheumatol. 2014. PMID: 24564981
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.
Owen C, Ngian GS, Elford K, Moore O, Stevens W, Nikpour M, Rabusa C, Proudman S, Roddy J, Zochling J, Hill C, Sturgess A, Tymms K, Youssef P, Sahhar J. Owen C, et al. Among authors: zochling j. Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):170-176. Epub 2016 Mar 24. Clin Exp Rheumatol. 2016. PMID: 27049330
The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
Thakkar V, Stevens W, Prior D, Rabusa C, Sahhar J, Walker JG, Roddy J, Lester S, Rischmueller M, Zochling J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M. Thakkar V, et al. Among authors: zochling j. Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):129-136. Epub 2016 May 23. Clin Exp Rheumatol. 2016. PMID: 27214686
N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
Thakkar V, Stevens WM, Prior D, Moore OA, Byron J, Liew D, Patterson K, Hissaria P, Roddy J, Zochling J, Sahhar J, Nash P, Tymms K, Celermajer D, Gabbay E, Youssef P, Proudman SM, Nikpour M. Thakkar V, et al. Among authors: zochling j. Arthritis Res Ther. 2012 Jun 12;14(3):R143. doi: 10.1186/ar3876. Arthritis Res Ther. 2012. PMID: 22691291 Free PMC article.
A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.
Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker J, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M. Hao Y, et al. Among authors: zochling j. Arthritis Res Ther. 2015 Jan 18;17(1):7. doi: 10.1186/s13075-015-0517-5. Arthritis Res Ther. 2015. PMID: 25596924 Free PMC article.
107 results